MARKET ACCESS

DOWNLOAD AGENDA

 

Access, Tuesday 19 March 2019

08:45

Organiser’s welcome Remarks

Joe Zhou
08:50

Chair’s opening Remarks

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group

Opening Keynote Plenary

David Lane
09:00

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
Byung-Geon Rhee
09:20

Looking east: Integrating Asia into the global era of innovative medicine

Panel discussion
09:40

Pharma Trends: Women health as the next focus

Women’s health goes beyond mother & childcare. For instance, women has a higher risk of cardiovascular diseases compared to men, hence there is a need to invest more on addressing the biological differences in mainstream disease studies to ensure a more effective, personalised treatment. In addition, big data & AI application on female subjects may also differ from male subjects, prompting a need to investigate how studies should be developed differently in the future. This panel brings experts to debate and discuss how femtech is shaping to be the next global pharma focus and the new areas of focus in women's healthcare.
10:20

Exhibition visit & networking refreshments

PATIENT ACCESS

Access
11:15

Chair's opening remarks

Edmund Lim
Access
11:20

Stakeholder mapping, acquisition & activation strategies

Nathan Kothandaraman
Access
11:40

The role of industry in facilitating low to mid income countries to build capabilities and healthcare accessibility

Panel discussion
Access
12:00

Collaborative efforts in building the common ground for better accessibility and treatment

  • Key actions to bridge the gaps between stakeholders to provide for population in need
  • Models in helping advocacy group to coordinate for better access to treatment
  • Building the common ground in promoting better collaboration between advocacy groups, government, pharma and other stakeholders
12:40

Exhibition Visit & Networking Lunch

EVIDENCE BASED APPROACH

Access
14:10

Chair’s opening remarks

Philippe Pinton
Access
14:20

Maximizing RWE and PRO in Regulatory & reimbursement processes

Jun Feng
Access
14:40

Making a value-outcome-based reimbursement model possible: How do we get there?

Jun Feng, Market Access Associate Director - Oncology, Japac, Abbvie
Panel discussion
Access
15:00

RWE as the basis of value-based reimbursement: Applications in APAC’s pharma industry

  • Overview of data-driven reimbursement process in APAC
  • Overcoming barriers to increase use of real world data
  • Improving quality of real world data
  • Standardising access and quality of RWE analytics
  • Working with payors and regulators on possible value based reimbursement model for innovative drugs and beyond
Jun Feng, Market Access Associate Director - Oncology, Japac, Abbvie
15:40

Exhibition Visit & Networking Refreshments

VALUE & AFFORDABILITY

Susanne Weissbaecker
Access
16:40

Providing affordable access to patients in developing countries and underserved communities

Shailendra Bajpai
Access
17:00

Cost management & innovative pricing strategies in high value disease management (topic to be confirmed)

Dr Sushant Sahastrabuddhe
Access
17:20

Technology transfer and Product Development Partnerships (PDPs) in making vaccines affordable

17:40

Networking Cocktail & End of Conference Day 1

last published: 19/Feb/19 03:35

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738